Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure (2022)
- Authors:
- Autor USP: BACHEGA, TÂNIA APARECIDA SARTORI SANCHEZ - FM
- Unidade: FM
- DOI: 10.1530/EJE-21-1085
- Subjects: CRIANÇAS; ADOLESCENTES; HIPERTENSÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European journal of endocrinology
- ISSN: 0804-4643
- Volume/Número/Paginação/Ano: v. 186, n. 5, p. 587-596, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
NEUMANN, Uta et al. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure. European journal of endocrinology, v. 186, n. 5, p. 587-596, 2022Tradução . . Disponível em: https://doi.org/10.1530/EJE-21-1085. Acesso em: 21 maio 2024. -
APA
Neumann, U., Linde, A. van der, Krone, R. E., Krone, N. P., Guven, A., Guran, T., et al. (2022). Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure. European journal of endocrinology, 186( 5), 587-596. doi:10.1530/EJE-21-1085 -
NLM
Neumann U, Linde A van der, Krone RE, Krone NP, Guven A, Guran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure [Internet]. European journal of endocrinology. 2022 ; 186( 5): 587-596.[citado 2024 maio 21 ] Available from: https://doi.org/10.1530/EJE-21-1085 -
Vancouver
Neumann U, Linde A van der, Krone RE, Krone NP, Guven A, Guran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure [Internet]. European journal of endocrinology. 2022 ; 186( 5): 587-596.[citado 2024 maio 21 ] Available from: https://doi.org/10.1530/EJE-21-1085 - Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency
- Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative
- Insuficiência adrenal
- Low adrenomedullary function predicts acute illness in infants with classical congenital adrenal hyperplasia
- Hiperplasia adrenal congênita
- Molecular -genetic causes underlying primary adrenal insufficiency. [Editorial]: current insights into diagnosis and treatment
- Mutações no gene da 21-hidroxilase em pacientes com hiperplasia adrenal congênita por deficiência da 21-hidroxilase, formas clássica e não clássica
- The Actual Incidence of Congenital Adrenal Hyperplasia in Brazil May Not be as High as Inferred - An Estimate Based on a Public Neonatal Screening Program in the State of Goiás
- Effects of endocrine disruptors in the development of the female reproductive tract
- Hiperplasia congênita das supras-renais
Informações sobre o DOI: 10.1530/EJE-21-1085 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
